Diseases of the Thyroid: A Management Review David Schneider, M.D. Perform appropriate laboratory testing to diagnose thyroid disease. Compare and contrast properties of antithyroid drugs such as methimazole and propyluracil. List indications for thyroid surgery. Choose among treatment options for hypothyroidism. Distinguish Graves disease from postpartum thyroiditis.
Thyroid Disease Stephanie L. Lee, M.D. Distinguish between subclinical and overt thyroid dysfunction. Detect the clinical consequences of subclinical hypo- and hyperthyroidism. Employ medical and/or nonmedical therapy to relieve symptoms of subclinical disease and prevent progression to overt thyroid disease. Evaluate the patient who presents with a suspected or diagnosed thyroid nodule. Determine which nodules require fine-needle aspiration biopsy.
Clinical Challenges in Treating Dyslipidemia Edwin E. Ferguson, M.D. and Lisa Christopher–Stine, M.D., M.P.H. Prescribe lifestyle changes (diet and exercise) and medical therapy to lower elevated triglyceride levels in patients with mixed dyslipidemia. Use the patient’s non-high-density lipoprotein cholesterol (non-HDL-C) level to better assess cardiovascular risk and target non-HDL-C as the goal of therapy. Combine high-dose prescription fish oil, niacin, or a fibrate with a statin to treat dyslipidemia. Diagnose myopathy based on the patient’s muscle histology. Recognize the clinical and pathologic features indicating the possibility of specificity for anti-200-kDa and anti-100-kDa autoantibodies associated with statin myopathy.
Obesity and Diabetes Francine R. Kaufman, M.D. and Mitchell E. Geffner, M.D. Identify modifiable and nonmodifiable factors that contribute to childhood obesity. Recognize risk factors for obesity and the development of T2DM. Recommend health and lifestyle interventions that can reduce body mass index and prevent the development of T2DM. Consider the role of genetic mutations in the development of childhood obesity and T2DM. Prescribe optimal treatment of obesity and T2DM in children.
Parathyroid Surgery James Norman, M.D., Edmund A. Pribitkin, M.D., John C. Kairys, M.D., Dr. Norman, John T. Potts Jr., M.D., and David Rosen, M.D. Determine the necessary components of a work-up for patients suspected of having primary hyperparathyroidism. Recognize which patients are candidates for parathyroidectomy. Describe key aspects of the surgical procedure for primary hyperparathyroidism. Discuss postoperative management of patients following parathyroidectomy. Discuss relevant issues surrounding surgery for hyperparathyroidism, including screening, role of sestamibi scanning, minimally invasive approach, anesthesia, intraoperative PTH, cost-effectiveness, and the role of medical therapy.
Update on Endocrinology Paul Mystkowski, M.D. and David S. Cooper, M.D. Establish a diagnosis in a patient with hypercalcemia. Advise a patient diagnosed with hypogonadism on the potential side effects associated with testosterone replacement therapy. Evaluate thyroid nodules and identify those that require surgery. Utilize radioiodine therapy to treat hyperthyroidism in an elderly patient. Administer appropriate levothyroxine therapy for treatment of hypothyroidism in an elderly patient.
Perspectives on Thyroid Disease Ralph P. Tufano, M.D., M.B.A., Glenn D. Braunstein, M.D., Gerard M. Doherty, M.D. and Edmund Pribitkin, M.D. List important recommendations about extent of initial thyroid surgery as proposed by ATA guidelines. Discuss current literature and initiatives to standardize terminology used for management of patients with thyroid nodules. Use current guidelines and indications to better manage patients with thyroid cancer by appropriately doing central or lateral neck dissection. Review indications for use of fine needle aspiration biopsy, rebiopsy, molecular markers, and frozen sections in management of patients with thyroid nodules. Consider extent of follow-up and use of same-day surgery, based on review of current trends in management of patients with thyroid nodules.
A Gland Review: Managing Thyroid and Parathyroid Disease Michael D. Whitaker, M.D. and Rose C. Christian, M.D. Identify risks associated with subclinical hypo- and hyperthyroidism. Determine causes of low thyrotropin levels. Select effective treatment for hyperthyroidism. Recognize clinical findings common in patients with primary hyperparathyroidism. Prescribe pharmacologic treatment, such as calcimimetic therapy, for hyperparathyroidism.
Threats to Health: Proteinuria/Metabolic Syndrome Robert C. Beach, M.D. and Vijay K. Bahl, M.D. Evaluate patients with persistent low-grade proteinuria and identify those who may require a renal biopsy. Prescribe pharmacotherapy to slow the progression of disease in a patient with diabetes mellitus (DM) who has been diagnosed with proteinuria. Utilize the National Cholesterol Education Program (NCEP) criteria for diagnosis of metabolic syndrome. Advise patients with metabolic syndrome about lifestyle changes to reduce body weight and prevent the development of type 2 DM (T2DM). and Prescribe appropriate pharmacotherapy for reducing the risks for T2DM and cardiovascular events in patients with metabolic syndrome.
Highlights from the 4th Annual Symposium: Contemporary Management of Thyroid and Parathyroid Diseases Ashok R. Shaha, M.D. Discuss incidence and prevalence of PMC and MTC. Discuss current guidelines from the American Thyroid Association (ATA) for the management of thyroid cancers. Weigh evidence on prognostic features and risks and benefits of various therapeutic approaches for the management of thyroid cancers. Assess the usefulness of various diagnostic tools, including novel molecular markers, in the management of thyroid cancers. Utilize appropriate treatment and follow-up for the management of PMC and MTC.
Additional Continuing Education Options Available...
If you have taken the current Endocrinology course listed above or if you are seeking additional Continuing Education credits in similar subject areas, please visit: Medical Courses Coming Soon where we have abbreviated listings of additional courses available.
ASI Now Offers 9 NEW Specialties! Click the links below for the current course outline and full information!
Here is what our clients are saying about American Seminar Institute's CME seminars...
"The Endocrinology Review provided relevant and interesting information, I enjoyed the lectures very much. The best thing about ASI is the ability for me to choose exactly where I want to complete my seminar each year.." Stephen,B., MD, Myrtle Beach, South Carolina
"This is such a painless and convenient way to earn my CME...I'll be back in January for my EMD seminar in Cancun, Mexico." Rosemary T., NP,Chesterfield, MI
..ASI's Endocrinology seminar was an excellent method of keeping up to date..I have already recommended your program to a number of my colleagues." Stanley R, Cape May, NJ
Back to Top of ASI's Endocrinology and Metabolic Disorders CME Review Page
